Bluejay Diagnostics, Inc. - Common Stock

Bluejay Diagnostics, Inc. - Common Stock Share · US0956333019 · BJDX (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Bluejay Diagnostics, Inc. - Common Stock
Analyst Grade Summary
gauge-img
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
1
0
0
No Price
01.05.2026 20:22
Current Prices from Bluejay Diagnostics, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
BJDX
USD
01.05.2026 20:22
2,07 USD
0,25 USD
+14,09 %
IEXG: IEX
IEX
BJDX
USD
01.05.2026 19:58
1,98 USD
0,17 USD
+9,12 %
Share Float & Liquidity
Free Float 86,85 %
Shares Float 393.912,00
Shares Outstanding 453.541,00
Company Profile for Bluejay Diagnostics, Inc. - Common Stock Share
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Company Data

Name Bluejay Diagnostics, Inc. - Common Stock
Company Bluejay Diagnostics, Inc.
Symbol BJDX
Website https://www.bluejaydx.com
Primary Exchange XNAS NASDAQ
ISIN US0956333019
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Indranil Dey
Country United States of America
Currency USD
Employees 0,0 T
Address 360 Massachusetts Avenue, 01720 Acton
IPO Date 2021-11-10

Stock Splits

Date Split
29.01.2026 1:4
18.11.2024 1:50
20.06.2024 1:8
24.07.2023 1:20

Ticker Symbols

Name Symbol
NASDAQ BJDX
More Shares
Investors who hold Bluejay Diagnostics, Inc. - Common Stock also have the following shares in their portfolio:
Cadence Bank
Cadence Bank Share
TAKEDA PHAR. 20/50
TAKEDA PHAR. 20/50 Bond